Results (3652)
Product information to be updated to raise awareness of known risk of agranulocytosis and facilitate its early detection and diagnosis
EMA recommends measures to minimise serious outcomes of known side effect with painkiller metamizole
![LLMs factsheet](https://www.ema.europa.eu/sites/default/files/styles/ema_listing/public/2024-09/2024-09_LLMs%20factsheet-2-_WEB_square_en.png.webp?itok=DGUL5rBL)
Guiding principles set out how EU medicine regulators can use LLMs in a safe, responsible and effective manner
The European Medicines Agency's (EMA) office is closed on Thursday 15 August 2024.
![Medical devices](https://www.ema.europa.eu/sites/default/files/styles/ema_listing/public/2024-07/2024-07_Medical_devices.jpeg.webp?itok=K8WyXGCY)
Free advice and guidance available for manufacturers and notified bodies
![Woman adjusting medicine package](https://www.ema.europa.eu/sites/default/files/styles/ema_listing/public/2024-07/2024-06_AMA-4-_WEB.png.webp?itok=i2pkSKXO)
Validating processes is an important step towards establishment of African Medicines Agency
![medicine pills and tablets](https://www.ema.europa.eu/sites/default/files/styles/ema_listing/public/2023-11/Web%20image_CHMP_standard_square.png.webp?itok=yjyfL_mv)
14 new medicines recommended for approval; another 11 medicines recommended for extension of therapeutic indications
Use of opioid medicines with Mysimba may lead to serious side effects
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.
PRAC elects new chair